staurosporine has been researched along with Huntington Disease in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Naia, L; Rego, AC; Ribeiro, M; Rodrigues, J; Silva, AC | 1 |
| Almeida, S; Cardoso, SM; Ferreira, IL; Grazina, M; Januário, C; Nascimento, MV; Oliveira, CR; Pratas, J; Rego, AC; Ribeiro, M; Santos, MJ | 1 |
| Almeida, S; de Brito, OM; Ferreira, IL; Lombardi, V; Louros, S; Oliveira, CR; Rego, AC; Ribeiro, M; Rosenstock, TR | 1 |
| Nagata, E; Ross, CA; Sawa, A; Snyder, SH | 1 |
| Bantubungi, K; Blum, D; Brotchi, J; Brouillet, E; Chtarto, A; Déglon, N; Galas, MC; Greco, A; Jacquard, C; Levivier, M; Minghetti, L; Pintor, A; Popoli, P; Schiffmann, SN; Tai, K; Tenenbaum, L | 1 |
| Bertram, L; Bissada, N; Deng, Y; Doty, CN; Graham, RK; Haigh, B; Hayden, MR; Leavitt, BR; Lu, G; Murphy, Z; Nicholson, DW; Pearson, J; Raymond, LA; Roy, S; Shehadeh, J; Slow, EJ; Warby, SC; Wellington, CL | 1 |
| Borchelt, DR; Cooper, JK; Dawson, TM; Dawson, VL; Delanoy, M; Herring, WJ; Kaminsky, Z; Khan, FA; Masone, J; Peters, MF; Ross, CA; Schilling, G; Sharp, AH | 1 |
| Cooper, J; Greenamyre, JT; Lawler, JF; Margolis, RL; Ross, CA; Sawa, A; Sharp, AH; Snyder, SH; Wiegand, GW | 1 |
| Chun, W; Johnson, GV; Lee, M; Lesort, M | 1 |
9 other study(ies) available for staurosporine and Huntington Disease
| Article | Year |
|---|---|
Oxidizing effects of exogenous stressors in Huntington's disease knock-in striatal cells--protective effect of cystamine and creatine.
Topics: Corpus Striatum; Creatinine; Cystamine; Enzymes; Humans; Huntington Disease; Hydrogen Peroxide; Oxidative Stress; Reactive Oxygen Species; Staurosporine | 2013 |
Mitochondrial-dependent apoptosis in Huntington's disease human cybrids.
Topics: Adult; Analysis of Variance; Apoptosis; Apoptosis Inducing Factor; Apoptosis Regulatory Proteins; bcl-2 Homologous Antagonist-Killer Protein; bcl-2-Associated X Protein; Bcl-2-Like Protein 11; Case-Control Studies; Caspase 3; Cell Line, Tumor; Citrate (si)-Synthase; DNA, Mitochondrial; Dose-Response Relationship, Drug; Electron Transport Complex III; Electron Transport Complex IV; Enzyme Inhibitors; Gene Expression Regulation; Humans; Huntington Disease; Intracellular Fluid; L-Lactate Dehydrogenase; Membrane Potential, Mitochondrial; Membrane Proteins; Mitochondria; Multienzyme Complexes; Nitrobenzoates; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Staurosporine; Subcellular Fractions; Superoxides; Teratocarcinoma; Time Factors; Trinucleotide Repeat Expansion | 2010 |
FK506 ameliorates cell death features in Huntington's disease striatal cell models.
Topics: Animals; Apoptosis; Blotting, Western; Caspase 3; Cell Death; Cell Line; Corpus Striatum; Cytosol; DNA Fragmentation; Humans; Huntingtin Protein; Huntington Disease; Immunosuppressive Agents; Mice; Mice, Transgenic; Mitochondria; Necrosis; Nerve Tissue Proteins; Neurons; Neuroprotective Agents; Nitro Compounds; Nuclear Proteins; Propionates; Staurosporine; Subcellular Fractions; Tacrolimus | 2011 |
Autophagosome-like vacuole formation in Huntington's disease lymphoblasts.
Topics: Adult; Apoptosis; Autophagy; Biomarkers; Cathepsin B; Cells, Cultured; Enzyme Inhibitors; Female; Humans; Huntingtin Protein; Huntington Disease; Immunohistochemistry; Lymphocytes; Male; Microscopy, Electron; Nerve Tissue Proteins; Nuclear Proteins; Phagosomes; Staurosporine; Stem Cells; Vacuoles | 2004 |
Minocycline in phenotypic models of Huntington's disease.
Topics: Animals; Calpain; Caspases; Cell Death; Cells, Cultured; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Encephalitis; Glutamic Acid; Huntingtin Protein; Huntington Disease; Male; Minocycline; Nerve Degeneration; Nerve Tissue Proteins; Neuroprotective Agents; Nitro Compounds; Nuclear Proteins; Phenotype; Propionates; Quinolinic Acid; Rats; Rats, Inbred Lew; Rats, Wistar; Staurosporine | 2005 |
Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin.
Topics: Active Transport, Cell Nucleus; Animals; Brain; Caspase 6; Caspases; Cell Nucleus; Humans; Huntingtin Protein; Huntington Disease; Hydrolysis; Mice; Mice, Transgenic; Mutation; N-Methylaspartate; Nerve Degeneration; Nerve Tissue Proteins; Neurons; Nuclear Proteins; Quinolinic Acid; Staurosporine | 2006 |
Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture.
Topics: Animals; Cell Line; Cell Nucleus; Glutamine; Humans; Huntingtin Protein; Huntington Disease; Kidney; Mice; Nerve Tissue Proteins; Neuroblastoma; Nuclear Proteins; Peptide Fragments; Repetitive Sequences, Nucleic Acid; Staurosporine; Transfection; Tumor Cells, Cultured | 1998 |
Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization.
Topics: Adolescent; Adult; Apoptosis; Caspase 3; Caspases; Cyanides; Enzyme Activation; Glutamine; Hematopoietic Stem Cells; Humans; Huntington Disease; Lymphocytes; Mitochondria; Staurosporine; Trinucleotide Repeats | 1999 |
Mutant huntingtin aggregates do not sensitize cells to apoptotic stressors.
Topics: Apoptosis; Caspase 3; Caspases; Enzyme Activation; Enzyme Inhibitors; Humans; Huntingtin Protein; Huntington Disease; Immunoblotting; Macromolecular Substances; Nerve Tissue Proteins; Neuroblastoma; Nuclear Proteins; Osmolar Concentration; Poly(ADP-ribose) Polymerases; Sorbitol; Staurosporine; Transgenes; Trinucleotide Repeat Expansion; Tumor Cells, Cultured | 2002 |